Clinical Trials Directory

Trials / Completed

CompletedNCT03676205

Platelet-Rich Plasma in Acute Muscle Injuries

Randomized Clinical Trial About the Therapeutic Use of Platelet-Rich Plasma (PRP) for the Treatment of Acute Muscular Injuries in Football Players.

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
41 (actual)
Sponsor
University of the Basque Country (UPV/EHU) · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

OBJECTIVE: To evaluate the effect of Platelet Rich Plasma (PRP) injection in muscle injuries. The investigators check football players in the acute phase of hamstrings or quadriceps injuries. Efficacy and safety are evaluated. There are two intramuscular infiltration of PRP (Ortho pras ® system) or a homeopathic product (Traumeel ®) in each of the football players. The number of days between the date of injury and the return to play, the pain, the recurrence and the adverse reactions are registered.

Detailed description

STUDY DESIGN: Randomized Clinical Trial. METHODS: 41 football players are included in the study. It is used randomly PRP injection or a homeopathic product in muscle injuries (hamstring), in the early stage (first 48-72 hours). One week later, the investigators do a second infiltration with the same product, always ultrasound guided. 3-4 weeks after the injury, different variables are evaluated: the injurie with ultrasounds , self-perception test, muscle strength, flexibility, jump and run. It is compared the elapsed time in days in each of the groups: RETURN TO PLAY. Furthermore, the PAIN, RECURRENCE RATE and ADVERSE REACTIONS are evaluated.

Conditions

Interventions

TypeNameDescription
BIOLOGICALPRPPlatelet-Rich Plasma
OTHERTraumeelHomeophatic Treatment

Timeline

Start date
2016-10-03
Primary completion
2019-04-08
Completion
2020-01-08
First posted
2018-09-18
Last updated
2020-01-22

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT03676205. Inclusion in this directory is not an endorsement.